Blood and CSF Homocysteine Levels in Alzheimer’s Disease: A Meta-Analysis and Meta-Regression of Case–Control Studies

OBJECTIVE: Hyperhomocysteinemia (HHcy), as an important risk factor for Alzheimer’s disease (AD), would aggravate cognitive dysfunction. This study aimed to investigate whether and to what degree the homocysteine (Hcy) levels in blood and cerebrospinal fluid (CSF) were elevated in AD patients compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ling, Xie, Xinhua, Sun, Yangyan, Zhou, Futao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586177/
https://www.ncbi.nlm.nih.gov/pubmed/36276430
http://dx.doi.org/10.2147/NDT.S383654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586177/
https://www.ncbi.nlm.nih.gov/pubmed/36276430
http://dx.doi.org/10.2147/NDT.S383654

Ejemplares similares